Breaking News Instant updates and real-time market news.

FB

Facebook

$179.80

2.2 (1.24%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

14:08
01/19/18
01/19
14:08
01/19/18
14:08

Facebook not bidding for Thursday Night Football rights, Bloomberg reports

Facebook (FB) has decided against bidding for the NFL's Thursday night football rights, Bloomberg reports, citing a person familiar with the matter. Facebook has bid for NFL's Thursday games in the past, according to the person. The streaming rights for the 2017 package went to Amazon (AMZN) for $50M, the report says, but Amazon has not said whether it will bid again.Reference Link

FB

Facebook

$179.80

2.2 (1.24%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

  • 19

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

FB Facebook
$179.80

2.2 (1.24%)

01/16/18
01/16/18
UPGRADE
Target $30

Buy
Twitter upgraded to Buy with $30 target at Aegis
As previously reported, Aegis analyst Victor Anthony upgraded Twitter (TWTR) two notches, to Buy from Sell, and set a $30 price target on the stock. Anthony believes 2018 will be an inflection point in owned and operated advertising for Twitter and he sees a return to double-digit growth in that area in 2019. He also sees the potential for improving monthly average user growth, sustained double-digit daily active user growth and thinks the stock could be included in the S&P 500 at some point. Additionally, Anthony sees Facebook's (FB) decision to de-emphasize public content making Twitter a more valuable resource for video and news, making it an even more appealing takeover candidate, he tells investors.
01/17/18
COWN
01/17/18
NO CHANGE
COWN
Digital Realty may have signed lease with Facebook, says Cowen
Cowen said Digital Realty (DLR) may have signed a lease with Facebook (FB) for 12MW in Northern Virginia.
01/18/18
KEYB
01/18/18
NO CHANGE
KEYB
Cost savings emerge as 'killer app' for artificial intelligence, says KeyBanc
Over the past 35 days, KeyBanc analyst Brent Bracelin hosted meetings at Adobe (ADBE), Autodesk (ADSK), Algorithmia, Cloudera (CLDR), Coupa (COUP), Facebook (FB), Guidewire (GWRE), Netflix (NFLX), NVIDIA (NVDA), Salesforce (CRM), SAP, Synopsys (SNPS), Twilio (TWLO), Tableau (DATA), Talend (TLND), Veeva (VEEV), Workday (WDAY), and Zendesk (ZEN) as part of an AI & Cloud-themed field trip. The analyst notes that cost savings have emerged as the "killer app" for artificial intelligence, and large enterprise interest in migrating back-office apps to cloud has been slow, but is picking up, conversational AI and bot activity is yielding real cost savings. Further, Bracelin sees 2018 as a defining year for enterprise AI applications, and is most impressed by enterprise AI initiatives at Microsoft (MSFT), Zendesk, Guidewire, and Adobe.
01/19/18
MSCO
01/19/18
NO CHANGE
Target $215
MSCO
Overweight
Facebook Watch early traction encouraging, says Morgan Stanley
Morgan Stanley analyst Brian Nowak said he was encouraged, and surprised, by the fact that the firm's survey of Facebook users indicated that 40% use Facebook Watch on a weekly basis and 24% are using it on a daily basis. Watch users also appear to skew younger, which is also a positive, as it speaks to the potential for Watch to become a longer-term habit, said Nowak, who keeps an Overweight rating and $215 price target on Facebook shares.
AMZN Amazon.com
$1,293.32

-1.68 (-0.13%)

01/18/18
WEDB
01/18/18
NO CHANGE
WEDB
Amazon not slowing down in hardlines, says Wedbush
Wedbush analyst Seth Basham continues to see risks from Amazon (AMZN) across the hardlines universe, "but all is not lost." The analyst argues that just as Amazon sees a need for physical retail in some categories, hardlines retailers that deliver a seamless customer experience across the physical and virtual worlds can survive, if not thrive. He believes Home Depot (HD) is the most advanced retailer he covers in responding to the paradigm shift in consumer shopping. Nonetheless, the analyst thinks all retailers need to continue to invest to avoid falling further behind, with Williams-Sonoma (WSM) most at risk from competitive pressures and/or much accelerated investment.
01/19/18
JEFF
01/19/18
NO CHANGE
Target $100
JEFF
Buy
Jefferies sees Kohl's rallying another 50%, ups target to $100
Jefferies analyst Randal Konik raised his price target for Kohl's (KSS) to $100 from $66 and says the stock could rise at least another 50%. The shares closed yesterday up 26c to $64.85. The retailer is "addressing the digital revolution head on" and surpassing peers with more emphasis on proprietary brands, partnering with Amazon.com (AMZN) and rightsizing square footage, Konik tells investors in a research note. He expects Kohl's sales growth to accelerate and margins to rise, and views current consensus estimates as "way too low." The company's off-mall real estate is an additional positive, as is the closing of peer stores, Konik adds. He remains a buyer of the stock.
01/19/18
PIPR
01/19/18
NO CHANGE
Target $1400
PIPR
Overweight
Amazon.com search index points to in-line Q4, says Piper Jaffray
Piper Jaffray analyst Michael Olson says his firm's Amazon Search Index indicates Q4 online unit growth will be 24% year-over-year, in line with Street expectations and a slight deceleration from 25% in Q3. He believes any material Q4 margin upside is unlikely as Amazon spends on Whole Foods. The analyst keeps an Overweight rating on the shares with a $1,400 price target.
01/19/18
COWN
01/19/18
NO CHANGE
COWN
Amazon doesn't look to be actively pushing into pharma, says Cowen
After reviewing data from various state pharmacy boards, Cowen analyst Charles Rhyee noted that no additional states beyond the 13 noted last year have issued new wholesale or retail licenses to Amazon so far, while some of its existing licenses have expired. From this, he concludes that Amazon is not actively pushing into pharma, but said this doesn't mean the e-commerce giant isn't interested in healthcare, just that it may be a different area than drug sales. Rhyee thinks a natural fit could be incorporating the company's Alexa voice assistant for some health care needs, he tells investors.

TODAY'S FREE FLY STORIES

08:15
06/19/18
06/19
08:15
06/19/18
08:15
General news
Housing Starts Permits to be reported at 08:30 »

May Housing Starts…

08:15
06/19/18
06/19
08:15
06/19/18
08:15
General news
Housing Starts to be reported at 08:30 »

May Housing Starts will…

VLKAY

Volkswagen

$0.00

(0.00%)

, AUDVF

Audi AG

$0.00

(0.00%)

08:13
06/19/18
06/19
08:13
06/19/18
08:13
Periodicals
Jailed Audi CEO pledges to cooperate with emissions-cheating probe, WSJ reports »

CEO of Volkswagen's…

VLKAY

Volkswagen

$0.00

(0.00%)

AUDVF

Audi AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$18.74

0.02 (0.11%)

, FBNK

First Connecticut

$26.05

0.15 (0.58%)

08:13
06/19/18
06/19
08:13
06/19/18
08:13
Conference/Events
People's United to host conference call »

Conference call to…

PBCT

People's United

$18.74

0.02 (0.11%)

FBNK

First Connecticut

$26.05

0.15 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

NTRA

Natera

$14.38

0.12 (0.84%)

08:09
06/19/18
06/19
08:09
06/19/18
08:09
Hot Stocks
Natera announces research collaboration with Institut Jules Bordet »

Natera announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

BKYI

BIO-key

$2.42

0.02 (0.83%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
BIO-key awarded U.S. patent for Utilization of Biometric Data »

BIO-key International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRON

Cronos Group

$6.77

-0.25 (-3.56%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
Cronos Group granted medicinal cannabis Manufacture License in Australia »

Cronos Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CVS

CVS Health

$67.73

-2.37 (-3.38%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
CVS Pharmacy: Prescription delivery now available nationwide »

CVS Pharmacy, the retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNA

Allena Pharmaceuticals

$13.48

-0.08 (-0.59%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
Allena Pharmaceuticals completes animal proof-of-concept study for ALLN-346 »

Allena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$17.78

0.1 (0.57%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Downgrade
Mattel rating change  »

Mattel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$14.68

2.655 (22.08%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Downgrade
Rent-A-Center rating change  »

Rent-A-Center downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXR

Citius Pharmaceuticals

$2.67

-0.03 (-1.11%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Hot Stocks
Citius Pharmaceuticals announces Mino-Lok is now a registered trademark »

Citius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$6.19

-0.91 (-12.82%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Hot Stocks
IRIDEX announces approval of CYCLO G6 Glaucoma Laser system in Korea »

IRIDEX announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, DIA

Diamonds Fund ETF

$249.72

-0.99 (-0.39%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Technical Analysis
Technical Take: Diamonds Fund ETF breaks uptrend support line in pre-market »

As trade war and other…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

DIA

Diamonds Fund ETF

$249.72

-0.99 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RSLS

ReShape Lifesciences

$3.07

-0.05 (-1.60%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
ReShape Lifesciences receives issue notification for ReShape Vest patent »

ReShape Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.55

-0.0816 (-12.92%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Syndicate
Matinas BioPharma raises $8M in a public offering »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISR

IsoRay

$0.45

0.0095 (2.16%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
IsoRay enters one-year employment contract with Lori Woods as Interim CEO »

IsoRay announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSKN

Strata Skin Sciences

$2.11

0.09 (4.46%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Strata announces 510(k) submission for Multi-Micro Dose tip accessory »

STRATA Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$202.60

1.06 (0.53%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Raytheon awarded $161M contract from U.S. Army »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LASR

nLight

$38.51

-0.05 (-0.13%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
nLight analyst commentary  »

nLight price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIBB

Hibbett Sports

$21.70

-0.1 (-0.46%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBNK

First Connecticut

$26.05

0.15 (0.58%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
Breaking Hot Stocks news story on First Connecticut »

First Connecticut trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$97.80

2.93 (3.09%)

, ANSS

Ansys

$177.91

0.17 (0.10%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Recommendations
PTC, Ansys, Rockwell Automation analyst commentary  »

PTC price target raised…

PTC

PTC

$97.80

2.93 (3.09%)

ANSS

Ansys

$177.91

0.17 (0.10%)

ROK

Rockwell Automation

$175.40

-2.19 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

NCR

NCR Corp.

$32.23

0.06 (0.19%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
NCR Corp. announces strategic alliance with TCS »

NCR Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$20.17

0.14 (0.70%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Syndicate
Easterly Government Properties 18M share Spot Secondary priced at $19.25 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.